The resultant increases in serum levels of GDF protein are used clinically as predictive biomarkers of morbidity and mortality in mitochondrial diseases, including those that induce mitochondrial DNA damage by disrupting the thymidine salvage pathway (28). The gene discussed is PAEP; the disease is inborn mitochondrial metabolism disorder.